FR2970152B1 - Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique - Google Patents
Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetiqueInfo
- Publication number
- FR2970152B1 FR2970152B1 FR1100029A FR1100029A FR2970152B1 FR 2970152 B1 FR2970152 B1 FR 2970152B1 FR 1100029 A FR1100029 A FR 1100029A FR 1100029 A FR1100029 A FR 1100029A FR 2970152 B1 FR2970152 B1 FR 2970152B1
- Authority
- FR
- France
- Prior art keywords
- omega
- fatty acids
- polyunsaturated fatty
- supplement
- food composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013305 food Nutrition 0.000 title abstract 2
- 241000195493 Cryptophyta Species 0.000 title 1
- 206010012689 Diabetic retinopathy Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 210000001525 retina Anatomy 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 241000199919 Phaeophyceae Species 0.000 abstract 1
- 102000000344 Sirtuin 1 Human genes 0.000 abstract 1
- 108010041191 Sirtuin 1 Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 230000002438 mitochondrial effect Effects 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1100029A FR2970152B1 (fr) | 2011-01-06 | 2011-01-06 | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique |
| PCT/FR2012/050002 WO2012093229A1 (fr) | 2011-01-06 | 2012-01-03 | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique |
| EP12702573.2A EP2661181A1 (fr) | 2011-01-06 | 2012-01-03 | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1100029A FR2970152B1 (fr) | 2011-01-06 | 2011-01-06 | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2970152A1 FR2970152A1 (fr) | 2012-07-13 |
| FR2970152B1 true FR2970152B1 (fr) | 2013-11-22 |
Family
ID=44358060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1100029A Active FR2970152B1 (fr) | 2011-01-06 | 2011-01-06 | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2661181A1 (fr) |
| FR (1) | FR2970152B1 (fr) |
| WO (1) | WO2012093229A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113662112A (zh) * | 2021-08-27 | 2021-11-19 | 大连工业大学 | 一种具有护眼功能的复合果蔬汁及其制备方法 |
| WO2024062077A1 (fr) | 2022-09-21 | 2024-03-28 | Bioatlantis Limited | Phlorotannins et alpha-fucanes pour traiter le diabète sucré de type 2 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005170837A (ja) * | 2003-12-10 | 2005-06-30 | Riken Vitamin Co Ltd | 海藻抽出物およびそれを含む糖質加水分解酵素阻害剤 |
| CA2541747A1 (fr) | 2004-08-17 | 2006-02-23 | Ocean Nutrition Canada Ltd. | Compositions d'ascophyllum et procedes |
-
2011
- 2011-01-06 FR FR1100029A patent/FR2970152B1/fr active Active
-
2012
- 2012-01-03 EP EP12702573.2A patent/EP2661181A1/fr not_active Withdrawn
- 2012-01-03 WO PCT/FR2012/050002 patent/WO2012093229A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR2970152A1 (fr) | 2012-07-13 |
| WO2012093229A1 (fr) | 2012-07-12 |
| EP2661181A1 (fr) | 2013-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Berbert et al. | Supplementation of fish oil and olive oil in patients with rheumatoid arthritis | |
| PH12015502307A1 (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
| Angeloni et al. | The role of diet in preventing and reducing cognitive decline | |
| WO2014074552A3 (fr) | Compositions et procédés pour diminuer les triglycérides sans augmenter les taux de ldl-c chez un sujet traité en même temps par la statine | |
| MX337585B (es) | Combinacion de componentes para la prevencion y el tratamiento de la debilidad. | |
| MX2011009507A (es) | Emulsiones de aceite en agua a base de pescado enriquecidas en omega-3 para nutricion parenteral. | |
| NZ757815A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| WO2013123139A8 (fr) | Procédés, compositions et dispositifs pour satisfaire aux besoins alimentaires en acides gras | |
| Asif | Chemical characteristics and nutritional potentials of unsaturated fatty acids | |
| WO2011097276A8 (fr) | Procédés et compositions pour traiter l'arthrite par de l'acide docosahexaénoïque | |
| EP2506848A4 (fr) | Substances permettant d'atténuer la survenue d'événements cardiaques majeurs qui contiennent un extrait de levure de riz rouge et des acides gras insaturés oméga 3 ou leur dérivé | |
| MX2013009007A (es) | Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. | |
| WO2008094825A3 (fr) | Compositions et procédés destinés à maintenir, renforcer, améliorer ou favoriser la santé des yeux | |
| Li et al. | Advances in fucoxanthin chemistry and management of neurodegenerative diseases | |
| NZ598529A (en) | Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage | |
| FR2970152B1 (fr) | Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique | |
| RU2016129079A (ru) | Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы | |
| Dangour et al. | Nutrition challenges for the twenty-first century | |
| EP2801356A3 (fr) | DHA et EPA pour la réduction du stress oxydatif | |
| PH12016501111A1 (en) | Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste | |
| CN103766507A (zh) | 一种具有保健功能的食用油 | |
| WO2012105816A3 (fr) | Composition destinée à prévenir et traiter le diabète et les complications du diabète comprenant une poudre d'amphicarpaea edgeworthii var. trisperma ou un extrait de celle-ci | |
| KR20150100227A (ko) | 여드름 피부 상태 개선용 건강기능식품의 조성물 | |
| van Rooyen | Bioactive compounds in red palm oil can modulate mechanisms of actions in in vitro anoxic perfused rat hearts | |
| Parzonko et al. | Anthocyanins-rich chokeberry fruit extract reduces endothelial progenitor cells senescence and protects against oxidative stress induced by angiotensin II |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| PLFP | Fee payment |
Year of fee payment: 10 |
|
| PLFP | Fee payment |
Year of fee payment: 11 |
|
| PLFP | Fee payment |
Year of fee payment: 12 |
|
| PLFP | Fee payment |
Year of fee payment: 13 |
|
| PLFP | Fee payment |
Year of fee payment: 14 |